Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs SCHLX overlap: 81% of top holdings shared

Bottom line

How much do FHLC and SCHLX overlap?

81% of their top holdings overlap by weight. 21 securities appear in both funds' top 25, making up 67.7% of FHLC's assets and 69.3% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.

FHLC holds far more positions (337 vs 65), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCSCHLX
Weight overlap (top 25)81%
Shared holdings21
Weight in shared holdings67.7%69.3%
Total positions33765
Expense ratio0.084%1.06%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings FHLC and SCHLX have in common

Holding% of FHLC% of SCHLXOverlap
Eli Lilly & Co13.35%13.85%13.35%
Johnson & Johnson8.93%6.19%6.19%
AbbVie Inc6.42%4.90%4.90%
UnitedHealth Group Inc5.44%5.73%5.44%
Merck & Co Inc4.66%4.85%4.66%
Thermo Fisher Scientific Inc3.09%3.46%3.09%
Amgen Inc3.00%2.88%2.88%
Abbott Laboratories2.66%2.39%2.39%
Gilead Sciences Inc2.34%2.78%2.34%
Pfizer Inc2.06%1.17%1.17%
Bristol-Myers Squibb Co1.93%1.50%1.50%
Intuitive Surgical Inc1.82%2.69%1.82%
Danaher Corp1.80%2.13%1.80%
Vertex Pharmaceuticals Inc1.76%2.45%1.76%
Stryker Corp1.62%2.61%1.62%
Medtronic PLC1.59%1.54%1.54%
McKesson Corp1.52%2.05%1.52%
Regeneron Pharmaceuticals Inc1.15%1.43%1.15%
Boston Scientific Corp1.00%2.10%1.00%
Cencora Inc0.83%1.26%0.83%
Cardinal Health Inc0.78%1.34%0.78%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. CVS Health Corp — 1.92%
  2. Elevance Health Inc — 1.19%
  3. Cigna Group/The — 1.06%
  4. HCA Healthcare Inc — 0.91%

Only in SCHLX

  1. AstraZeneca PLC — 3.80%
  2. Novartis AG — 2.90%
  3. Novo Nordisk A/S — 1.73%
  4. Roche Holding AG — 1.24%

Asset mix

Asset typeFHLCSCHLX
Stocks99.7%99.6%
Cash & short-term funds0.2%0.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryFHLCSCHLX
US96.5%85.7%
CH0.1%5.2%
GB0.5%3.8%
IE2.2%1.5%
DK—1.7%
NL0.1%1.0%
FR—1.0%
BM0.2%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FHLC and SCHLX overlap?
About 81% by weight. 21 securities appear in both funds' top 25 holdings; they make up 67.7% of FHLC's assets and 69.3% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do FHLC and SCHLX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, AbbVie Inc, Merck & Co Inc.
Should I own both FHLC and SCHLX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, FHLC or SCHLX?
FHLC is broader, with 337 positions versus 65 for SCHLX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.